Recombinant Plasmodium protein

MSP-2 (T9/105 12/6)

Type
Recombinant Plasmodium protein
Description
MSP2 Type B. Comproses the R2 region plus the C-terminal family-specific domain
Derived from
P. falciparum T9 isolate, clone 105
Fusion partner
GST
History
The isolate T9 was collected on 7th April 1980 from a malaria patient at Mae Sod (near Tak) 543km north of Bangkok, Thailand. Case history unclear. T9/105 is a clone derived by limiting dilution from that isolate. DNA from T9/105 was used to produce the T9/105 (12/6) antigen.
UK Biosafety level
1
Availability
Available. Enquire.
References

Thiathong et al., 1984

Polley et al., 2006

MSP-2 G1 8/6

Type
Recombinant Plasmodium protein
Description
MSP-2 dimorphic region serotype A (3D7 type) derived from parasite isolate G1. Cloned wioth primers 8 and 6 (see MSP-2 diagrams)
Derived from
P. falciparum
Fusion partner
GST
Source
Jana McBride
UK Biosafety level
1
References

Polley et al., 2006

MSP-2 K1 12/6

Type
Recombinant Plasmodium protein
Description
MSP-2 dimorphic region type B
Derived from
P. falciparum (isolate K1) MSP-2 gene
Fusion partner
GST
UK Biosafety level
1
Availability
Available. Enquire.
Links
doi: 10.1016/j.vaccine.2005.06.030. Epub 2005 Jul 27. High levels of serum ant…
References

Polley SD, Conway DJ, Cavanagh DR, McBride JS, Lowe BS, Williams TN, Mwangi
TW, Marsh K. High levels of serum antibodies to merozoite surface protein 2 of
Plasmodium falciparum are associated with reduced risk of clinical malaria in
coastal Kenya. Vaccine. 2006 May 8;24(19):4233-46.

MSP-2 K1 13/3

Type
Recombinant Plasmodium protein
Description
MSP2 R1 repeat antigen type B plus part of the N-terminal conserved region
Derived from
P. falciparum (isolate K1) MSP-2 gene
Fusion partner
GST
UK Biosafety level
1
Availability
Available. Enquire.
Links
High levels of serum antibodies to merozoite surface protein 2 of Plasmodium fa…
References

Polley SD, Conway DJ, Cavanagh DR, McBride JS, Lowe BS, Williams TN, Mwangi
TW, Marsh K. High levels of serum antibodies to merozoite surface protein 2 of
Plasmodium falciparum are associated with reduced risk of clinical malaria in
coastal Kenya. Vaccine. 2006 May 8;24(19):4233-46.

MSP-2 K1 5/3

Type
Recombinant Plasmodium protein
Description
MSP2 R1 repeat antigen type B
Derived from
P. falciparum
Fusion partner
GST
UK Biosafety level
1
Availability
Available. Enquire.
References

Polley et al., 2006

Recombinant Plasmodium protein

Please state in any acknowledgements:

 

Recombinant Plasmodium protein was obtained from The European Malaria Reagent Repository (http://www.malariaresearch.eu).

It is a condition of the supply of this reagent that you also cite the reference and source given above in any publication.

Contact

Email: emrr@ed.ac.uk